Jacob C. Zellmer, Marina B. Tarantino, Michelle Kim, Selene Lomoio, Masato Maesako, György Hajnóczky, Raja Bhattacharyya
4 min
This study investigates how the physical gap width between mitochondria and the endoplasmic reticulum (ER)—collectively known as mitochondria-associated ER membranes (MAMs)—regulates the production of amyloid-beta (Aβ) in neurons. Given that MAMs are implicated in Alzheimer's disease (AD) pathology, the authors sought to determine whether modulating the structural stability of these contacts could serve as a therapeutic strategy to shift amyloidogenic processes toward non-amyloidogenic ones.
The researchers utilized a 3D neural model of AD (ReN-GA cells) that recapitulates key pathological features, including Aβ-driven neurofibrillary tangle formation. They employed fluorescence resonance energy transfer (FRET) and fluorescence-based biological linkers to stabilize MAMs at specific gap widths: tight (~6 nm), basal (~25 nm), and loose (~40 nm). Using electron microscopy, ELISA for Aβ quantification, and live-cell kymography, they assessed how these structural variations influenced Aβ generation and the axonal transport of mitochondria.
The study reveals that MAM gap width is a critical determinant of Aβ generation. Stabilizing tight MAMs (~6 nm) significantly exacerbated Aβ production, while stabilizing loose MAMs (~40 nm) had the opposite effect, reducing Aβ levels. Furthermore, the researchers observed that tight MAMs significantly slowed the axonal velocity of mitochondria, suggesting that the physical stabilization of these contacts directly impacts mitochondrial mobility and, consequently, the amyloidogenic pathway. The authors propose that there is a specific threshold of MAM stability that dictates whether the cellular environment promotes or inhibits Aβ generation.
These findings suggest that MAMs are not merely structural components but dynamic regulators of AD pathology. By identifying that specific gap widths correlate with Aβ levels, the study provides a potential therapeutic target: modulating MAM stability rather than attempting to disrupt them entirely. This approach avoids the potential toxicity associated with complete MAM disruption, offering a more nuanced strategy for early-stage AD intervention.
INTRODUCTION: We previously demonstrated that regulating mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) affects axonal Aβ generation in a well-characterized three-dimensional (3D) neural Alzheimer's disease (AD) model. MAMs vary in thickness and length, impacting their functions. Here, we examined the effect of MAM thickness on Aβ in our 3D neural model of AD. METHODS: We employed fluorescence resonance energy transfer (FRET) or fluorescence-based MAM stabilizers, electron microscopy, Aβ enzyme-linked immunosorbent assay (ELISA), and live-cell imaging with kymography to assess how stabilizing MAMs of different gap widths influence Aβ production and MAM axonal mobility. RESULTS: Stabilizing tight MAMs (∼6 nm gap width) significantly increased Aβ levels, whereas basal (∼25 nm) and loose MAMs (∼40 nm) maintained or reduced Aβ levels, respectively. Tight MAMs reduced mitochondrial axonal velocity compared to basal MAMs, while loose MAMs showed severely reduced axonal distribution. DISCUSSION: Our findings suggest that stabilizing MAMs of specific gap widths, particularly in axons, without complete destabilization could be an effective therapeutic strategy for AD. HIGHLIGHTS: The stabilization of MAMs exacerbates or ameliorates Aβ generation from AD neurons in a MAM gap width-dependent manner. A specific stabilization threshold within the MAM gap width spectrum shifts the amyloidogenic process to non-amyloidogenic. Tight MAMs slow down mitochondrial axonal transport compared to lose MAMs offering a quantitative method for measuring MAM stabilization.
Sam: Both, it turns out—and the second effect is just as important as the first. When the gap was too tight, the mitochondria became sluggish. They stopped moving along the axons—the long, wire-like projections that nerve cells use to send signals across the brain. A mitochondrion that can't travel can't deliver energy where it's needed. So a tight gap doesn't just increase toxic protein output. It also starves distant parts of the neuron of power.
Alex: So adjusting that distance is doing two things at once: reducing the harmful protein and restoring the cell's ability to move energy around.
Sam: That's what the study suggests. The researchers describe this gap as something like a dimmer switch—a structural control point that sets the pace of a whole chain of cellular events. The implication is that targeting this mechanism could offer a meaningful way to intervene earlier in the disease, closer to its source, rather than responding to the damage it leaves behind. Whether that translates into a viable treatment is still an open question, but the underlying logic is worth paying attention to.
Alex: It's a different way of thinking about the problem—less about mopping up, more about turning down the tap. Thanks for listening to ResearchPod.